Advertising
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »
COMMENT
Will have an FDA decision in July. Whether they get approval or not, there will be a huge move up or down. Options strategy? Market knows this is going to have an impact so this gets priced into the options. Very difficult to do this.
Consumer Products
TOP PICK
Liver cancer treatment. They isolate the liver and then pump more chemo to kill cancer cells. Survivor rate has gone from 4 to 23 months. Market potential is about 5-6 billion globally. Stock dropped when a scientist said it wouldn't work but FDA protocol showed results were significant.
Consumer Products
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Delcath Systems(DCTH-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Delcath Systems is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Delcath Systems(DCTH-Q) Frequently Asked Questions

What is Delcath Systems stock symbol?

Delcath Systems is a OTC stock, trading under the symbol DCTH-Q on the (). It is usually referred to as or DCTH-Q

Is Delcath Systems a buy or a sell?

In the last year, there was no coverage of Delcath Systems published on Stockchase.

Is Delcath Systems a good investment or a top pick?

Delcath Systems was recommended as a Top Pick by on . Read the latest stock experts ratings for Delcath Systems.

Why is Delcath Systems stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Delcath Systems worth watching?

In the last year, there was no coverage of Delcath Systems published on Stockchase.

What is Delcath Systems stock price?

On , Delcath Systems (DCTH-Q) stock closed at a price of $.